Member of the Association of American Physicians
The scientist’s investigation covers issues in Internal medicine, Acute kidney injury, Kidney disease, Surgery and Creatinine. His study in Acute kidney injury is interdisciplinary in nature, drawing from both Renal function, Intensive care medicine, Biomarker, Prospective cohort study and Risk factor. His work focuses on many connections between Renal function and other disciplines, such as Myocardial infarction, that overlap with his field of interest in Nephropathy.
His Kidney disease research integrates issues from Clinical trial, Mortality rate, Randomized controlled trial, Disease and Severity of illness. In his work, Risk of mortality and Predictive value of tests is strongly intertwined with Gastroenterology, which is a subfield of Surgery. The Creatinine study combines topics in areas such as Urology, Acute tubular necrosis, Confidence interval, Urine and Cardiac surgery.
His scientific interests lie mostly in Internal medicine, Acute kidney injury, Kidney disease, Renal function and Creatinine. His Internal medicine research incorporates themes from Surgery and Cardiology. Chirag R. Parikh interconnects Intensive care medicine, Perioperative, Cardiac surgery, Dialysis and Cohort in the investigation of issues within Acute kidney injury.
His research integrates issues of Proteinuria, Proportional hazards model, Immunology and Risk factor in his study of Kidney disease. His Renal function study combines topics from a wide range of disciplines, such as Hazard ratio, Kidney and Urology. His work deals with themes such as Gastroenterology, Urinary system, Urine and Acute tubular necrosis, which intersect with Creatinine.
Chirag R. Parikh focuses on Internal medicine, Acute kidney injury, Kidney disease, Biomarker and Kidney. His Nephrology, Prospective cohort study, Cardiac surgery, Hazard ratio and Interquartile range study are his primary interests in Internal medicine. His Acute kidney injury study integrates concerns from other disciplines, such as Randomized controlled trial, Intensive care medicine, Creatinine, Dialysis and Cohort.
Chirag R. Parikh interconnects Urinary system, Proteinuria, Biopsy and Renal function in the investigation of issues within Kidney disease. His work in Biomarker addresses subjects such as Cohort study, which are connected to disciplines such as Clinical endpoint. His Kidney research includes themes of Incidence, Transplantation and Urology.
Chirag R. Parikh spends much of his time researching Internal medicine, Kidney disease, Acute kidney injury, Renal function and Biomarker. Chirag R. Parikh frequently studies issues relating to Gastroenterology and Internal medicine. His research integrates issues of Nephrology, Blood pressure, Urinary system, Creatinine and Proteinuria in his study of Kidney disease.
Creatinine connects with themes related to Intensive care medicine in his study. The study incorporates disciplines such as Placebo, Dialysis, Randomized controlled trial and Donor selection in addition to Acute kidney injury. His Renal function research is multidisciplinary, relying on both Urine, Kidney, Proportional hazards model and Urology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis.
Steven G. Coca;Swathi Singanamala;Chirag R. Parikh.
Kidney International (2012)
Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis
Steven G. Coca;Bushra Yusuf;Bushra Yusuf;Michael G. Shlipak;Michael G. Shlipak;Amit X. Garg.
American Journal of Kidney Diseases (2009)
Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review
S.G. Coca;S.G. Coca;R. Yalavarthy;J. Concato;J. Concato;C.R. Parikh;C.R. Parikh.
Kidney International (2008)
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery.
C.R. Parikh;J. Mishra;H. Thiessen-Philbrook;B. Dursun.
Kidney International (2006)
Urine IL-18 Is an Early Diagnostic Marker for Acute Kidney Injury and Predicts Mortality in the Intensive Care Unit
Chirag R. Parikh;Edward Abraham;Marek Ancukiewicz;Charles L. Edelstein.
Journal of The American Society of Nephrology (2005)
Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis
Xiaolei Zhu;Shenhong Wu;William L. Dahut;Chirag R. Parikh.
American Journal of Kidney Diseases (2007)
Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis
Sri G. Yarlagadda;Steven G. Coca;Richard N. Formica;Emilio D. Poggio.
Nephrology Dialysis Transplantation (2008)
Urinary interleukin-18 is a marker of human acute tubular necrosis.
Chirag R. Parikh;Alkesh Jani;Vyacheslav Y. Melnikov;Sarah Faubel.
American Journal of Kidney Diseases (2004)
Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation.
C. R. Parikh;A. Jani;J. Mishra;Q. Ma.
American Journal of Transplantation (2006)
Acute kidney injury in cirrhosis
Guadalupe Garcia-Tsao;Chirag R. Parikh;Antonella Viola;Antonella Viola.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: